Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/129204
DC FieldValue
dc.titleBreast tissues in transsexual women - A nonprostatic source of androgen up-regulated production of prostate-specific antigen
dc.contributor.authorGoh, V.H.H.
dc.date.accessioned2016-11-02T03:18:01Z
dc.date.available2016-11-02T03:18:01Z
dc.date.issued1999
dc.identifier.citationGoh, V.H.H. (1999). Breast tissues in transsexual women - A nonprostatic source of androgen up-regulated production of prostate-specific antigen. Journal of Clinical Endocrinology and Metabolism 84 (9) : 3313-3315. ScholarBank@NUS Repository.
dc.identifier.issn0021972X
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/129204
dc.description.abstractThe present study made use of the female transsexual model and sought to evaluate the contributions of the ovarian, endometrial, and breast tissues to the androgen up-regulated production of prostate specific antigen (PSA). Serum levels of PSA were significantly raised in female transsexuals before surgery, after long-term androgen therapy (mean ± SE = 35.3 ± 6.2 pg/mL) when compared with female transsexuals before surgery, but with no androgen therapy (mean ± SE = 1.53 ± 0.25 pg/mL). In addition, in androngenized female transsexuals, after surgery, concentrations of PSA (mean ± SE = 14.5 ± 2.8 pg/mL) were significantly lowered compared with androngenized female transsexuals after surgery, but the levels were, nevertheless, significantly higher than in normal females. Monthly im injection of 250 mg Sustanon-250 to female transsexuals had raised serum testosterone levels to within the male range. In five subjects, in whom serial measurements were taken, serum testosterone levels were greatly raised 24 h after the testosterone therapy; the mean level (±SE) was 19.5 ± 2.1 ng/mL. But in spite of these high testosterone levels, serum PSA levels (mean ± SE = 2.2 ± 0.9 pg/mL) were not significantly raised. However, after 12 months of androgen therapy, the mean (±SE) PSA level in these five subjects was 47 ± 11.6 pg/mL and was significantly higher than the mean level in nonandrogenized female transsexuals. The present study confirmed that high levels of testosterone were able to up-regulate PSA production in women. This up-regulation of PSA production is both a dose- and time-dependent process. Furthermore, the evidence indicates that breast tissues are possibly a nonprostatic source of androgen up-regulated production of PSA women.
dc.sourceScopus
dc.typeArticle
dc.contributor.departmentOBSTETRICS & GYNAECOLOGY
dc.description.sourcetitleJournal of Clinical Endocrinology and Metabolism
dc.description.volume84
dc.description.issue9
dc.description.page3313-3315
dc.description.codenJCEMA
dc.identifier.isiutNOT_IN_WOS
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Page view(s)

18
checked on Jul 19, 2019

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.